Kodak Pharma-SUNY Geneseo Hub Targets Manufacturing Talent Gap
SUNY Geneseo and Kodak's pharma unit launch a collaborative hub to train graduates for GMP-regulated biotech and pharmaceutical roles.
Breaking News
May 04, 2026
Pharma Now Editorial Team

SUNY Geneseo and Eastman Kodak's pharmaceuticals unit have established a collaborative hub designed to prepare graduates for roles in biotech and pharmaceutical manufacturing, signaling a direct industry response to persistent workforce shortages across GMP-regulated environments. As plant heads and QA directors continue to flag qualified talent as a critical operational constraint, structured academia-industry pipelines are becoming a measurable part of workforce strategy rather than a peripheral initiative.
The partnership centers on hands-on experimental work intended to support testing of emerging pharmaceutical products, giving students exposure to the applied science that underpins process validation and product quality systems. For QA and regulatory affairs leads, the significance lies in graduates entering the sector with practical familiarity with pharmaceutical testing environments, reducing onboarding timelines and the gap between academic training and GMP-compliant practice.
What the collaboration involves:
- A jointly established collaborative hub between SUNY Geneseo and Kodak's pharma unit
- Experiments designed to incorporate support for testing of emerging pharmaceutical products
- A stated focus on preparing graduates specifically for the biotech and pharmaceutical sectors
Kodak's pharmaceutical unit, operating within a heavily regulated manufacturing context, brings industry-side requirements directly into the academic curriculum design. This model mirrors broader ICH Q10-aligned thinking around knowledge management, where building organizational capability begins upstream of the plant floor. For the industry at large, the Kodak-Geneseo structure offers a replicable case study in how regional manufacturers can anchor local talent pipelines without relying solely on national recruitment.
Source: Pharmaceutical Industry News, published 4 May 2026, via EIN Presswire.
